Abstract
Background
A pilot study was conducted to evaluate the therapeutic results of intravitreal ganciclovir injection as a loading dose with or without the following oral valganciclovir for the treatment of cytomegalovirus (CMV) anterior uveitis in immunocompetent patients.
Methods
Six consecutive patients in whom active CMV anterior uveitis was detected by polymerase chain reaction assay of the aqueous humor were enrolled between January 2006 and December 2008. These patients received an intravitreal injection of ganciclovir (2 mg/0.05 ml) as a loading dose. Subsequent use of oral valganciclovir (900 mg twice a day) was determined according to the severity of the post-injection aqueous inflammation. Immune status and anterior chamber reaction of individual patients, visual acuity, intraocular pressure (IOP) at study entry, and follow-up intervals were examined.
Results
The mean patient-month follow-up period after intravitreal injection was 14.7 months (range, 12–22 months). Two patients received only the intravitreal ganciclovir injection once and four patients had received the following oral valganciclovir for average 2.3 months (range, 1–4 months). With this treatment strategy, the best-corrected visual acuity of the patients improved or stabilized; the IOP and the inflammation of anterior chamber of the patients were well controlled at all time points and there were no treatment-associated complications by the end of follow-up.
Conclusions
In patients with CMV anterior uveitis, intravitreal ganciclovir injection as a loading dose with or without the following oral valganciclovir can control the inflammation and IOP well.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH (2008) Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 145:834–840. doi:S0002-9394(07)01051-3 [pii] 10.1016/j.ajo.2007.12.015
de Schryver I, Rozenberg F, Cassoux N, Michelson S, Kestelyn P, Lehoang P, Davis JL, Bodaghi B (2006) Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br J Ophthalmol 90:852–855. doi:bjo.2005.086546 [pii] 10.1136/bjo.2005.086546
Hart WM Jr, Reed CA, Freedman HL, Burde RM (1978) Cytomegalovirus in juvenile iridocyclitis. Am J Ophthalmol 86:329–331
Teoh SB, Thean L, Koay E (2005) Cytomegalovirus in aetiology of Posner-Schlossman syndrome: evidence from quantitative polymerase chain reaction. Eye 19:1338–1340. doi:6701757 [pii] 10.1038/sj.eye.6701757
van Boxtel LA, van der Lelij A, van der Meer J, Los LI (2007) Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 114:1358–1362
Van Gelder RN (2008) Idiopathic no more: clues to the pathogenesis of Fuchs heterochromic iridocyclitis and glaucomatocyclitic crisis. Am J Ophthalmol 145:769–771. doi:S0002-9394(08)00146-3 [pii] 10.1016/j.ajo.2008.02.010
Mietz H, Aisenbrey S, Ulrich Bartz-Schmidt K, Bamborschke S, Krieglstein GK (2000) Ganciclovir for the treatment of anterior uveitis. Graefes Arch Clin Exp Ophthalmol 238:905–909
Markomichelakis NN, Canakis C, Zafirakis P, Marakis T, Mallias I, Theodossiadis G (2002) Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy. Ophthalmology 109:879–882. doi:S0161-6420(02)00961-2 [pii]
Winston DJ, Busuttil RW (2003) Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients. Transplantation 75:229–233
Henderly DE, Freeman WR, Causey DM, Rao NA (1987) Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology 94:425–434
Anduze-Faris BM, Fillet AM, Gozlan J, Lancar R, Boukli N, Gasnault J, Caumes E, Livartowsky J, Matheron S, Leport C, Salmon D, Costagliola D, Katlama C (2000) Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS (London, England) 14:517–524
Koizumi N, Suzuki T, Uno T, Chihara H, Shiraishi A, Hara Y, Inatomi T, Sotozono C, Kawasaki S, Yamasaki K, Mochida C, Ohashi Y, Kinoshita S (2008) Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology 115:292–297. doi:S0161-6420(07)00571-4 [pii] 10.1016/j.ophtha.2007.04.053 e293
Stocher M, Leb V, Bozic M, Kessler HH, Halwachs-Baumann G, Landt O, Stekel H, Berg J (2003) Parallel detection of five human herpes virus DNAs by a set of real-time polymerase chain reactions in a single run. J Clin Virol 26:85–93
Gault E, Michel Y, Dehee A, Belabani C, Nicolas JC, Garbarg-Chenon A (2001) Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol 39:772–775
Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516
Kim EC, Margolis TP (2006) Hypertensive iridocyclitis. Br J Ophthalmol 90:812–813. doi:90/7/812 [pii] 10.1136/bjo.2006.091876
Koizumi N, Yamasaki K, Kawasaki S, Sotozono C, Inatomi T, Mochida C, Kinoshita S (2006) Cytomegalovirus in aqueous humor from an eye with corneal endotheliitis. Am J Ophthalmol 141:564–565. doi:S0002-9394(05)01030-5 [pii] 10.1016/j.ajo.2005.09.021
Yamauchi Y, Suzuki J, Sakai J, Sakamoto S, Iwasaki T, Usui M (2007) A case of hypertensive keratouveitis with endotheliitis associated with cytomegalovirus. Ocul Immunol Inflamm 15:399–401. doi:783645110 [pii] 10.1080/09273940701486795
Boivin G, Gilbert C, Gaudreau A, Greenfield I, Sudlow R, Roberts NA (2001) Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis. J Infect Dis 184:1598–1602
De Clercq E (2004) Antiviral drugs in current clinical use. J Clin Virol 30:115–133
Young S, Morlet N, Besen G, Wiley CA, Jones P, Gold J, Li Y, Freeman WR, Coroneo MT (1998) High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis. Ophthalmology 105:1404–1410
Janoria KG, Boddu SH, Wang Z, Paturi DK, Samanta S, Pal D, Mitra AK (2009) Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina. J Ocul Pharmacol Ther 25:39–49. doi:10.1089/jop.2008.0040
Hu H, Jabs DA, Forman MS, Martin BK, Dunn JP, Weinberg DV, Davis JL (2002) Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis. J Infect Dis 185:861–867
Chee SP, Jap A (2008) Presumed Fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol 146:883–889. doi:S0002-9394(08)00698-3 [pii] 10.1016/j.ajo.2008.09.001 e881
Author information
Authors and Affiliations
Corresponding author
Additional information
None of the authors has any financial interest in this study.
The authors have full control of all primary data and agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review the data if requested.
Drs. Hwang and Lin contributed equally as co-first authors to this manuscript.
Rights and permissions
About this article
Cite this article
Hwang, YS., Lin, KK., Lee, JS. et al. Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis. Graefes Arch Clin Exp Ophthalmol 248, 263–269 (2010). https://doi.org/10.1007/s00417-009-1195-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-009-1195-2